Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 4Osteoporosis 3Prostatic Neoplasms 2Pain 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Myocardial Ischemia 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Heart Diseases 1Disease Progression 1Coronary Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Bone Diseases, Metabolic 1Bone Diseases 1

Interventions

Zoledronic Acid 3Denosumab 3Vitamin D 2Risedronic Acid 2Letrozole 2Toremifene 1Ibandronic Acid 1Geritol 1Calcium Carbonate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Bone Diseases, Metabolic × Calcium × Clear all
NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
72 enrolled 8 charts
LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡